%0 Journal Article
%T WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma
%A Afonso A. Pinto
%A Bruno M. Costa
%A Carlos Clara
%A Carlos Cust¨®dia
%A Cl¨¢udia C. Faria
%A C¨¦line S. Gon£¿alves
%A Eduarda P. Martins
%A Emmanuel Chautard
%A Fernando Pardal
%A Joana Vieira de Castro
%A Manuel Melo Pires
%A Marta Pojo
%A Nuno Sousa
%A Ricardo Taipa
%A Rui M. Reis
%A Sandro Queir¨®s
%J Theranostics
%D 2018
%I Ivyspring International Publisher
%R 10.7150/thno.25025
%X Glioblastoma (GBM) is a universally fatal brain cancer, for which novel therapies targeting specific underlying oncogenic events are urgently needed. While the WNT pathway has been shown to be frequently activated in GBM, constituting a potential therapeutic target, the relevance of WNT6, an activator of this pathway, remains unknown.
%K biomarker
%K glioblastoma
%K oncogene
%K prognosis
%K WNT6
%K WNT pathway
%U http://www.thno.org/v08p4805.htm